Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma

Figure 9

The proportions of immune cell types in HNSCC patients: (a) the mean proportions of 22 immune cell types in the GSE65858 cohort; (b) the mean proportions of 22 immune cell types in the TCGA HNSCC cohort.

(a)

(b)